Resveratrol‐mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation

Raffaele Frazzi, Riccardo Valli, Ione Tamagnini, +3

International Journal of Cancer

Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines

Andrea Cavazzoni, Roberta Alfieri, Caterina Carmi, +9

Molecular Cancer Therapeutics

The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections

Luciano Polonelli, Arturo Casadevall, Yu Han, +16

Medical Mycology

Mucosal VaccinationAntifungal AgentAllergyExperimental Fungal InfectionsImmunology +10

Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma

Raffaele Frazzi, Eleonora Zanetti, Mariaelena Pistoni, +4

Leukemia Research

Epigenetic ChangeImmunologyPathologySirt1 MethylationEpigenetics +15

In vitro Activity of Monoclonal and Recombinant Yeast Killer Toxin-like Antibodies Against Antibiotic-resistant Gram-positive Cocci

Stefania Conti, Walter Magliani, Simona Arseni, +5

Molecular Medicine

In Vitro Leishmanicidal Activity of a Monoclonal Antibody mimicking a Yeast Killer Toxin

Dianella Savoia, C. Avanzini, Stefania Conti, +3

Journal of Eukaryotic Microbiology

Protozoan ParasitesAntiparasitic AgentImmunologyImmunotherapyVitro Leishmanicidal Activity +14

Inhibition by Yeast Killer Toxin-like Antibodies of Oral Streptococci Adhesion to Tooth Surfaces in an Ex Vivo Model

Stefania Conti, Walter Magliani, Simona Arseni, +4

Molecular Medicine

Droplet digital PCR is a sensitive tool for the detection of <i>TP53</i> deletions and point mutations in chronic lymphocytic leukaemia

Raffaele Frazzi, Veronica Bizzarri, Laura Albertazzi, +4

British Journal of Haematology

Killer anti-idiotypes in the control of fungal infections.

Walter Magliani, Stefania Conti, Simona Arseni, +3

PubMed

Antifungal AgentKiller Anti-idiotypesInternal ImageImmunologyClinical Mycology +6

KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells

Raffaele Frazzi, Vincenza Ylenia Cusenza, Mariaelena Pistoni, +4

Oncology Reports